News

Enhancements offer clients cross-study oversight through mobile-enabled reporting and analysis.

A study has found that the adoption of new transparent reporting standards may have contributed to a significant reduction in the percentage of studies reporting positive research findings among large-budget clinical trials funded by the National Heart, Lung and Blood Institute.

Synthon’s glatiramer acetate, a potential generic version of Copaxone®1 for the treatment of relapsing remitting multiple sclerosis is currently being reviewed by the U.S. Food and Drug Administration.

Sorrento will develop and market these 4 mAbs for the North American, European and Japanese market.

Collaboration to discover and develop antisense drugs for cardiovascular, metabolic and renal diseases.

Codexis to receive $5 million in upfront payment.

Adding Patheon as a contract manufacturer, in addition to Evonik Corporation, bolsters manufacturing capacity for planned commercialization of company's lead program.

Researchers have found a previously unknown population of cells in mice that function as liver stem cells. The finding could aid drug testing and increase understanding of liver biology and disease.

Atomic structure of HIFs to drive discovery of new drugs to treat cancer.

The outcome of the study is expected in 2016.